Research-backed compound with potential health benefits. Acts as a methyl donor, which helps lower homocysteine (good for your heart). It may also improve power output and muscular endurance for workouts.
Reviewed March 2026
Source: Cholewa 2018 systematic review + Trepanowski 2011
In a randomised double-blind crossover trial in 12 resistance-trained men, 14 days of betaine at 1.25 g twice daily raised bench throw power and isometric bench press force compared with placebo, with no change in jump squat power or repetitions completed; a meta-analysis of 17 trials in 317 participants reported a modest pooled effect on maximal strength of 0.47 standardised mean difference for regimens of at least 7 days.
Where a trial measured an actual number, we show it next to the claim. It is the average across the trials, never a promise about one person.
A small to moderate gain in maximal strength (standardized effect 0.47), largest in the lower body.
Healthy people aged 15 to 60, pooled across 17 trials.
Read at the source. The magnitude sits beside the same trial the claim already cites. It describes what the trials measured, never what any one person will feel.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Betaine is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
The body has two routes for converting homocysteine back into methionine, and betaine and folate each drive one of them. Folate works through the methionine synthase route while betaine works through a separate liver route, so together they support normal one-carbon metabolism and methylation.
The folate route that recycles homocysteine to methionine relies on vitamin B12 as its cofactor, whereas betaine drives a route that does not need B12 at all. Pairing them gives the body overlapping ways to regenerate methionine and keep methylation reactions supplied.
Building creatine in the body is one of the largest draws on S-adenosylmethionine, the cell's main methyl donor, and betaine helps regenerate the methionine that S-adenosylmethionine is rebuilt from. Both molecules also act as osmolytes that draw water into muscle cells, which is the usual reason performance formulas combine them.
Betaine recycles homocysteine back to methionine, while vitamin B6 is the cofactor for the separate transsulfuration branch that sends surplus homocysteine on to cysteine. Covering both the recycling side and the disposal side supports steady homocysteine handling within normal metabolism.
Choline is oxidised to betaine in the liver and kidney, so betaine covers part of choline's methyl-donor duty. That leaves more of the choline pool available for phospholipid and acetylcholine synthesis.
Betaine hands a methyl group to homocysteine to regenerate methionine, and methionine is the direct precursor of SAM-e. The two sit one enzymatic step apart on the same cycle.
Betaine gives up its methyl groups stepwise, becoming dimethylglycine and then glycine. Glycine is the end point of betaine's methyl donation and both feed the same one-carbon pool.
Homocysteine is remethylated by two parallel routes, the folate-dependent one that runs on methylfolate and the betaine-dependent BHMT route. Either arm can carry more of the load when the other is limited.
BHMT, the enzyme that moves betaine's methyl group onto homocysteine, is a zinc metalloenzyme. Zinc status therefore sits directly underneath betaine's main biochemical job.
Riboflavin becomes FAD, the cofactor for MTHFR on the folate arm of homocysteine remethylation. It keeps that route running alongside the one betaine drives.
Endogenous creatine synthesis consumes a large share of the body's SAM-derived methyl groups. Supplemental creatine lowers that methyl demand while betaine restores methyl supply from the other side.
Carnitine biosynthesis requires SAM-dependent methylation of protein-bound lysine. Betaine's methyl donation feeds the same pool that route draws from.
Phosphatidylcholine is built by SAM-dependent methylation of phosphatidylethanolamine through PEMT. Betaine supplies methyl groups for that route and spares dietary choline from being oxidised for the same purpose.
Homocysteine not remethylated by betaine passes down transsulfuration toward cysteine. NAC supplies cysteine directly, so the pair meets the same junction from opposite directions.
Lecithin is a dietary source of choline, and betaine spares choline from oxidation for methyl groups. Together they keep more choline available for membrane phospholipids.
Betaine-homocysteine methyltransferase transfers one methyl group from betaine to homocysteine, and the product is methionine. Methionine then goes on to S-adenosylmethionine, the cell's universal methyl donor. The two sit directly either side of one enzyme.
Betaine pulls homocysteine back toward methionine by remethylation, which competes with the transsulfuration branch that produces cysteine. Which branch dominates depends on methionine load, S-adenosylmethionine levels and B6 status. The direction of the interaction is set by the pathway, not by the dose alone.
Because cysteine is the rate-limiting input for glutathione, anything that shifts homocysteine away from transsulfuration also shifts the substrate supply for glutathione. Betaine is one such influence. This is a pathway-level consequence and has not been measured as a glutathione outcome here.
Serine feeds one-carbon units to folate through serine hydroxymethyltransferase, supporting the folate-dependent route of homocysteine remethylation. Betaine drives the folate-independent route through BHMT. The two routes run in parallel in liver and kidney.
Both molecules act as organic osmolytes that cells accumulate to hold volume under osmotic stress, taurine broadly and betaine especially in the kidney medulla. They are handled by different transporters, so accumulation of one does not preclude the other. The shared role is established cell physiology rather than a measured combined effect.
Betaine is an osmolyte and electrolytes set the osmotic gradient it responds to, so the two act on the same fluid-handling system from different sides. A randomised study of betaine during passive heat stress in men examined fluid balance and heat tolerance measures. Read that as a fluid-handling context for the pairing rather than a tested combination.
Both appear in pre-exercise formulas, bicarbonate as an extracellular buffer and betaine as an osmolyte and methyl donor. The mechanisms do not overlap, which is the argument for combining rather than against it. No combination trial is cited here.
Beta-alanine raises muscle carnosine, an intracellular buffer, while betaine works through methyl donation and cell osmolarity. Both are common in the same pre-workout blend for that reason. The pairing is formulation convention with separate mechanisms, not a demonstrated additive result.
Caffeine acts through adenosine receptor antagonism and central drive; betaine does not touch that system. They are stacked together as a matter of product design. Any combined effect on performance measures has not been established here.
Whey is a concentrated source of methionine, and a methionine load raises homocysteine, which is the substrate betaine's enzyme acts on. Higher protein intake therefore increases the traffic through the pathway betaine feeds. Homocysteine is a marker here, not an outcome.
This applies to the hydrochloride form specifically. Betaine hydrochloride releases hydrochloric acid on dissolution, lowering gastric pH, and pepsinogen only converts to active pepsin below about pH 5. The acid is the enabling step for the enzyme; the anhydrous form does not do this.
Acid-stable protease blends are commonly paired with betaine hydrochloride because gastric acidity governs the early stage of protein breakdown. The rationale is pH, and it applies only to the hydrochloride form. Pancreatic enzymes, which work at intestinal pH, gain nothing from it.
Non-haem iron is more soluble in an acidic stomach, and betaine hydrochloride lowers gastric pH on dissolution. That is the mechanistic argument for pairing the hydrochloride form with an iron salt. It does not apply to betaine anhydrous, and no absorption trial is cited here.
Myo-inositol is another compatible organic osmolyte that renal medullary cells accumulate alongside betaine, each with its own transporter. Cells adjust the mix rather than relying on one. The relationship is descriptive cell physiology with no combination data cited.
A 2026 mouse study reported that betaine supplementation attenuated markers of impaired glucose handling induced by a high selenium intake. That is an animal model and the readouts are markers rather than clinical outcomes. It suggests an interaction worth flagging at high selenium intakes and nothing more.
Nothing specific on file for Betaine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.Betaine is trimethylglycine, glycine wearing three methyl groups on its nitrogen. It carries a permanent positive charge at one end and a negative one at the other, making it a zwitterion that dissolves easily in water.
An enzyme called betaine-homocysteine methyltransferase hands one methyl group from betaine over to homocysteine, making methionine and dimethylglycine. It's the folate-free route for that conversion, and it runs mostly in liver and kidney.
The methionine made this way is converted to S-adenosylmethionine, the methyl donor your body uses for DNA, proteins, phospholipids and neurotransmitters.
Your own betaine comes from choline, oxidised inside mitochondria first to betaine aldehyde and then to betaine. That trip runs one way only, so betaine can't be turned back into choline.
It comes from one of two places. Sugar beet processing leaves behind a liquid rich in betaine, which can be separated out, or it can be built directly from two simple industrial chemicals. Both end up as the same white crystalline powder, which is then dried and tested.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Two routes reach the same molecule. The extraction route starts from sugar beet processing streams, where betaine occurs naturally at high concentration in the molasses left after sucrose crystallisation. The synthetic route starts from trimethylamine and chloroacetic acid, both commodity chemicals.
Trimethylamine displaces the chloride of chloroacetic acid to give the quaternary ammonium carboxylate directly. The reaction is simple and high-yielding, which is why the synthetic route dominates supply.
Betaine is separated from molasses using simulated moving bed chromatography, the same class of equipment used to recover residual sucrose, then concentrated.
Either stream is crystallised from water or aqueous alcohol and dried to a free-flowing white solid. The finished molecule is identical whichever route produced it; the difference sits in the impurity profile and the origin declaration.
Material is assayed for betaine content, chloride where relevant, and heavy metals. Anhydrous material is kept dry because it is hygroscopic; hydrochloride material is made by salt formation with hydrochloric acid.
The dried crystals are milled and blended. Because anhydrous betaine picks up moisture from air, blends often carry a flow aid and are packed with a desiccant.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
These are the studies our verdict leans on, chosen from the 993 we read for Betaine. The full linked list is below.
12 sources behind our Betaine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 3,367 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Betaine is, not how risky it is. A report is not proof Betaine caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
